UB Paderborn / Katalog / Suche / in CDI

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

Journal of hematology and oncology, 2018-09, Vol.11 (1), p.120-11, Article 120

2018

Link zum Volltext

Verfügbarkeit prüfen

Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study

eLife, 2023-11, Vol.12

2023

Link zum Volltext

Verfügbarkeit prüfen

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer

Frontiers in pharmacology, 2022-06, Vol.13, p.820437-820437

2022

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment

Frontiers in oncology, 2021-07, Vol.11, p.632357-632357

2021

Link zum Volltext

Verfügbarkeit prüfen

Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy

Current cancer drug targets, 2022-07, Vol.22 (6), p.530

2022

Link zum Volltext

Verfügbarkeit prüfen

The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors

Cancer treatment reviews, 2015-07, Vol.41 (7), p.623-633

2015

Link zum Volltext

Verfügbarkeit prüfen

Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up

Breast cancer research and treatment, 2022, Vol.191 (1), p.97-105

2022

Link zum Volltext

Verfügbarkeit prüfen

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer

Frontiers in genetics, 2023-03, Vol.14, p.1125970-1125970

2023

Link zum Volltext

Verfügbarkeit prüfen

A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis

BMC cancer, 2019-11, Vol.19 (1), p.1125-1125, Article 1125

2019

Link zum Volltext

Verfügbarkeit prüfen

Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer

Experimental hematology & oncology, 2022-09, Vol.11 (1), p.1-65, Article 65

2022

Link zum Volltext

Verfügbarkeit prüfen

The emerging role of RNA N6-methyladenosine methylation in breast cancer

Biomarker research, 2021-05, Vol.9 (1), p.1-39, Article 39

2021

Link zum Volltext

Verfügbarkeit prüfen

Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer

Biomarker research, 2021-04, Vol.9 (1), p.28-13, Article 28

2021

Link zum Volltext

Verfügbarkeit prüfen

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages

Cancer medicine (Malden, MA), 2023-09, Vol.12 (18), p.18850-18860

2023

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab Deruxtecan for Breast Cancer

The New England journal of medicine, 2022-06, Vol.386 (24), p.2346-2347

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes as adjuvant chemotherapy in triple-negative breast cancer: 8.1 years median follow-up on a randomized clinical trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.529-529

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological Differences and Prognostic Value of Hypoxia-Inducible Factor-2α Expression for Gastric Cancer: Evidence From Meta-Analysis

Medicine (Baltimore), 2016-02, Vol.95 (7), p.e2871-e2871

2016

Link zum Volltext

Verfügbarkeit prüfen

The intra-tumor heterogeneity of ER and HER2 expression in patients with ER-positive and HER2-positive breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e12550-e12550

2021

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 expression and TOP3A mutation as prognostic factors for adjuvant chemotherapy in triple negative breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.541-541

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China

Journal of gastrointestinal surgery, 2016-04, Vol.20 (4), p.700-707

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term disease free survival of gastric mixed adenoneuroendocrine carcinoma treated with multimodality therapy: A case report

Molecular and clinical oncology, 2018-05, Vol.8 (5), p.653-656

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China

Medicine (Baltimore), 2016-08, Vol.95 (31), p.e4420-e4420

2016

Link zum Volltext

Verfügbarkeit prüfen

Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database

Annals of translational medicine, 2022-12, Vol.10 (24), p.1351-1351

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update

Expert opinion on pharmacotherapy, 2018-06, Vol.19 (8), p.795-807

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of High Altitude on Clinicopathological Features and Prognosis after R0 Resection for Gastric Cancer: A Population-Based Multicenter Study

Journal of environmental pathology, toxicology and oncology, 2017, Vol.36 (1), p.1

2017

Link zum Volltext

Verfügbarkeit prüfen

Construction and application of the Synechocystis sp.PCC6803-ftnA in microbial contamination control in a coupled cultivation and wastewater treatment

环境科学学报：英文版, 2016 (8), p.174-181

Yalei Zhang Chunmin Zhang Xuefei Zhou Zheng Shen Fangchao Zhao Jianfu Zhao

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment

Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy

The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors

Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer

A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis

Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer

The emerging role of RNA N6-methyladenosine methylation in breast cancer

Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer

The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages

Trastuzumab Deruxtecan for Breast Cancer

Efficacy of epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes as adjuvant chemotherapy in triple-negative breast cancer: 8.1 years median follow-up on a randomized clinical trial

Clinicopathological Differences and Prognostic Value of Hypoxia-Inducible Factor-2α Expression for Gastric Cancer: Evidence From Meta-Analysis

The intra-tumor heterogeneity of ER and HER2 expression in patients with ER-positive and HER2-positive breast cancer

PD-L1 expression and TOP3A mutation as prognostic factors for adjuvant chemotherapy in triple negative breast cancer

Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China

Long-term disease free survival of gastric mixed adenoneuroendocrine carcinoma treated with multimodality therapy: A case report

Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China

Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database

Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update

Impact of High Altitude on Clinicopathological Features and Prognosis after R0 Resection for Gastric Cancer: A Population-Based Multicenter Study

Construction and application of the Synechocystis sp.PCC6803-ftnA in microbial contamination control in a coupled cultivation and wastewater treatment

Suchergebnisse filtern